What Do Colon Cancer Survival Rates by Stage Really Mean for Your Prognosis?

Key Takeaways

• Colon cancer survival rates are calculated based on disease stage, with survival rates declining as the cancer advances into later stages.
• Other factors that affect prognosis include the tumor grade and molecular profile, lymph node involvement, whether the tumor can be resected, and the patient’s overall health.
• Because every case of cancer is unique, the oncologist’s individual assessment matters more for patient prognosis than population-based statistics.
• RCCA oncologists develop personalized treatment plans to optimize outcomes, helping patients achieve remission or longer survival at all stages of cancer.

What Is Colon Cancer?

Colon cancer develops in the lining of the colon. It most commonly arises in the mucosa, or the innermost layer of tissue. The cancer starts as a polyp, a growth on the inner lining of the colon. While colonic polyps initially are non-cancerous, many of them can become cancerous if they are not removed. Polyps become cancerous when their cells mutate and spread rapidly. The mutated cells form a tumor and, eventually, may spread to other parts of the body through a process called metastasis.

Colon cancer incidence is somewhat higher among men than women, but both sexes are susceptible to developing the disease. While colon cancer is more prevalent among people aged 50 years and older, the disease is becoming more common in younger adults.

What Is a 5-Year Relative Survival Rate?

The 5-year relative survival rate is a statistic based on cancer survival data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database. The number is calculated by comparing people with the same type and stage of cancer to people in the general population. If the 5-year relative survival rate for a stage of cancer is 80%, that means that people who have that cancer are about 80% as likely to live for at least five years as people who don’t have that cancer.

5-year survival rates are population-level statistics. While they can help people understand how many patients survive for five years after diagnosis, they are not individual predictions. An individual’s prognosis is unique based on a variety of factors, including the type of cancer he or she has, its stage, its molecular properties, and the person’s overall health.

What Are Colon Cancer Survival Rates by Stage?

Colon cancer survival rates are partially predicted based on stage. Cancer staging is a system for describing how far the cancer has progressed based on the tumor’s size and its spread – if any — to other tissues. This information helps oncologists provide a prognosis, meaning a prediction of the patient’s likely course, and to develop an appropriate treatment plan.

Stage I Colon Cancer Survival Rate

Stage I is also called localized colon cancer. At this stage, the cancer is found only inside the colon. It has not grown through the colon wall or spread to other tissues. Stage I colon cancer has the highest survival rate. Surgery is the mainstay of treatment for Stage I colon cancer. Because the cancer is localized, it is relatively easy to eliminate with a low risk of recurrence. The 5-year relative survival rate is 91%.

Stage II and III Colon Cancer Survival Rates

Stages II and III are called regional colon cancer. At Stage II, the tumor has grown through the colon wall and might involve other tissues near the colon. At Stage III, the cancer has also spread to some nearby lymph nodes. Treatment is more difficult but still generally produces good outcomes. The 5-year relative survival rate is 74%.

Stage II vs. Stage III: What’s The Difference?

While Stage II and Stage III colon cancers are classified similarly in terms of relative survival rates, they require different treatment approaches. Stage II disease often is managed solely with surgery, although radiation therapy sometimes is administered after surgery. Stage III colon cancer is more advanced and has a higher likelihood of recurring. As a result, treatment plans for Stage III cancer are usually more aggressive than treatments for Stage II. Chemotherapy is often recommended after surgery to kill any cancer cells that remain. This second phase of treatment reduces the risk of cancer recurrence.

Stage IV Colon Cancer Survival Rates

Stage IV is also called distant or metastatic colon cancer. At this stage, cancer cells are found in distant parts of the body. The SEER database lists the 5-year relative survival rate as 13%. In reality, however, Stage IV outcomes vary widely. The prognosis depends heavily on the type of cancer and where it has metastasized, with some patients achieving long-term survival.

How New Treatments Change the Game

Targeted therapy and immunotherapy have transformed outcomes for distant colon cancer. Targeted therapy works by attacking the processes that fuel cancer’s spread, such as by blocking the proteins that signal cancer cells to grow. Immunotherapy, on the other hand, harnesses the power of the patient’s immune system to fight cancer. Both treatments typically lead to longer survival for patients with Stage IV colon cancer.

Stage	5-year survival rate	Description	Treatment Options
I	91%	Cancer is found only in the colon.	Surgery
II	74%	Cancer is found only in the colon and some nearby structures.	Surgery, sometimes followed by radiation therapy
III	74%	Cancer is found in the colon, some nearby structures, and some lymph nodes.	Surgery with adjuvant chemotherapy to prevent recurrence
IV	13%	Cancer has spread throughout the body.	Chemotherapy, targeted therapy, or immunotherapy

 

What Other Factors Affect Colon Cancer Prognosis?

While the cancer’s stage at diagnosis is critical when determining prognosis, it is not the only factor to consider. RCCA oncologists make sure to evaluate all factors to achieve the utmost precision when assessing a patient’s prognosis.

Tumor Grade

In addition to stages, colon cancers are also described with grades. This label describes how abnormal the cancer cells appear when studied under a microscope:

• G1: The cancer cells look similar to normal colon cells.
• G2: The cancer cells look slightly abnormal.
• G3: The cancer cells look highly abnormal.
• G4: The cancer cells look extremely abnormal.

The more abnormal the cancer cells look, the faster they are likely to reproduce. This makes cancer grading an effective way to determine how aggressive the cancer is.

Molecular Profile

When determining cancer grade, oncologists may also evaluate a tumor’s molecular profile. Specific genes and characteristics may make the cancer responsive to certain therapies, giving oncologists more options when planning treatment. Valuable features include microsatellite instability, which indicates the cancer’s responsiveness to immunotherapy, and genetic mutations that can be attacked with targeted therapy.

Lymph Node Involvement

The lymph nodes are tiny glands found throughout the body. They are components of the lymphatic system, where they play a vital role in trapping harmful invaders. Cancer that has spread to the lymph nodes is highly likely to spread further. This is because the cancer cells can now access the lymphatic stream, which can carry them to distant parts of the body.

Resectability

Resectability describes whether a tumor can be completely removed with surgery. Some tumors are small and relatively uniform in shape. These tumors typically can be completely removed without leaving cancer cells behind. However, if the tumor is large or irregularly shaped, or if there are numerous tumors in the colon, surgical removal becomes more difficult and the patient’s prognosis is less favorable.

Age and Overall Health

Finally, oncologists consider the patient’s age and overall condition. Colon cancer can cause significant complications, including anemia, dehydration, malnutrition, and weight loss. The younger and healthier patients are, the more easily they will tolerate these complications. Healthy patients can also handle more aggressive treatments, giving them more options for care.

How Does Treatment Affect Colon Cancer Survival?

Because each case of colon cancer is different, there is no one-size-fits-all treatment. Instead, RCCA oncologists develop personalized treatment plans for each patient they serve. By adapting treatments to the cancer type and stage, they help patients achieve the best possible outcomes.

Surgery as the First-Line Treatment

Surgery is the primary treatment for Stage I and II colon cancer. Depending on the cancer’s extent, the surgeon may perform a partial colectomy to remove only part of the colon or a total colectomy to remove the whole colon. Some surgeries may be followed by radiation therapy to kill any cancer cells left behind. For many patients, however, surgery is the only required treatment.

Adjuvant Chemotherapy for Stage III Survival

Stage III colon cancer is usually treated with surgery followed by chemotherapy. Chemotherapy uses strong drugs to kill rapidly dividing cells, such as cancer cells. Used before surgery, it can shrink a tumor to increase its resectability. Used afterward, it can kill cancer cells in neighboring tissue and lymph nodes. Both approaches greatly increase the patient’s chances of long-term survival. When chemotherapy is used after surgery, it is termed “adjuvant,” or accompanying, treatment.

Targeted Therapies for Metastatic Cancer

Targeted therapy is a recent innovation that can improve survival rates for late-stage, metastatic colon cancer. It uses personalized drugs that precisely target cancer cells without damaging healthy tissue. The FDA has approved two types of targeted therapy for colon cancer treatment:

• Anti-VEGF therapy: Drugs like bevacizumab prevent the formation of new blood vessels, thus slowing or halting a key mechanism for cancer metastasis.
• Anti-EGFR therapy: Drugs such as cetuximab and panitumumab block the signals that tell cancer cells to divide, and can be effective in treating colon cancers marked by specific molecular profiles.

Immunotherapy for MSI-High Colon Cancer

Microsatellite instability (MSI) is a molecular feature of cancers that prevents a tumor’s DNA from correcting errors when it divides. Tumors with high MSI are recognizable to the immune system. As a result, they respond well to immunotherapy. Checkpoint inhibitors block the proteins that cancers use to hide from the immune system, letting the immune system detect and attack MSI-high cancer cells.

Clinical Trials for Stage IV Cancer

Finally, patients may have access to clinical trials evaluating therapies for their particular stage and type of colon cancer. These cutting-edge studies assess the safety and effectiveness of new drugs or treatment approaches still in development. By participating, patients can receive early access to new treatments that may improve outcomes.

What Questions Should Patients Ask Their Oncologists?

When discussing a cancer diagnosis, the oncologist’s assessment of a patient’s specific situation matters far more than a population-based statistic. Instead of looking at 5-year relative survival rates, patients should ask their oncologists questions about their own case. Questions to ask include:

• What is my cancer stage?
• What are the cancer’s grade and molecular profile?
• What are the recommended treatment options for my cancer?
• What is the expected outcome from each treatment?
• Is my cancer likely to respond well to immunotherapy or targeted therapy?
• Do I have access to any clinical trials that might improve my prognosis?

Patients also should not hesitate to seek a second opinion. By talking to other oncologists, patients with cancer can clarify their prognosis and learn about more options that might improve their survival.

Find Expert Colon Cancer Care Near You in NJ, CT, MA, and the Washington, D.C., Area

Colon cancer survival rates are increasing, and Regional Cancer Care Associates (RCCA) is on the cutting edge of the curve. We provide advanced and personalized treatments at more than 20 locations near you across New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area, close to patients’ homes. Contact RCCA today to learn more about survival rates or to request an appointment with an oncologist.

Frequently Asked Questions About Colon Cancer Survival Rates

What is the survival rate for colon cancer?

The overall 5-year relative survival rate for colon cancer is 63%, but individual patient prognoses (outlooks) vary widely based on the cancer type, stage, grade, and other factors.

What is the survival rate for Stage IV colon cancer?

The 5-year relative survival rate for Stage IV colon cancer is 13%. While this statistic appears low, the actual survival rate is highly variable depending on a wide range of factors. Some patients can achieve long-term survival with the right treatments.

How has colon cancer survival improved in recent years?

Colon cancer survival has improved due to better screening and more advanced treatments. Cancer is often detected earlier than it previously was, and new treatments are more effective at eliminating or controlling it.

What factors most affect colon cancer prognosis?

The most important factors for colon cancer prognosis are the cancer stage, grade, molecular profile, lymph node involvement, and whether the tumor can be resected (removed with surgery). The patient’s age and overall health also are key factors. 

What is the difference between the 5-year survival rate and the cure rate?

The 5-year relative survival rate refers to the number of patients who are still alive five years after diagnosis. The cure rate, on the other hand, refers to the number of patients who achieve total remission. Many patients survive for years without achieving remission.

Does early detection really improve colon cancer survival rates?

Yes! Early detection improves colon cancer survival rates. Colon cancer is more treatable in early stages, leading to better outcomes and longer-term survival.

How do I talk to my doctor about my prognosis?

Talk to your doctor about your prognosis by asking questions about your specific situation. By learning more about the factors that affect your prognosis, you can understand what the prognosis means for you and can make informed decisions about treatment options.